Blood-Pressure Targets in Hypertension Management
Journal The New England Journal of Medicine (NEJM) Volume / Issue Vol. 394, No. 10 — March 5, 2026 Type […]
Blood-Pressure Targets in Hypertension Management Read More »
Apixaban or Rivaroxaban in Acute Venous Thromboembolism?
What Does the COBRRA Trial Published in NEJM Tell Us? Venous thromboembolism (VTE) is considered the third most common cause
Apixaban or Rivaroxaban in Acute Venous Thromboembolism? Read More »